PISCATAWAY, NJ – Camber Pharmaceuticals continues to expand its portfolio of HIV treatments with the addition of 800 mg Darunavir Tablets [da-ROON-a-veer], supplied in bottles of 30.
This new strength joins Camber’s previously launched 600 mg Darunavir Tablets, introduced two years ago. Darunavir Tablets are the generic equivalent of Prezista.
Darunavir Tablets co-administered with ritonavir (darunavir tablets/ritonavir), in combination with other antiretroviral agents, is indicated for the treatment of human immunodeficiency virus (HIV-1) infection in adult and pediatric patients 3 years of age and older.
To learn more about this product, visit: https://www.camberpharma.com/products/darunavir-2/
